Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Gubra looks beyond metabolism, hopes for first portfolio company this year

The Copenhagen-based drugmaker Gubra's present is mostly about obesity. Its future will need to be about a much broader pipeline. The company has a portfolio of weight loss drug candidates but is moving into the ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 27 October →